Kenji Hashimoto

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Robert J. Motzer, Romain Banchereau, Habib Hamidi et al. · Cancer Cell · 2020 · 561 citations · Full text

Medicine, Cancer Biology, Oncology +16

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Kobe Yuen, Lifen Liu, Vinita Gupta et al. · Nature Medicine · 2020 · 439 citations · Full text

Life Sciences, Immunology, Oncology +16

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

Mahrukh Huseni, Lifen Wang, Joanna E. Klementowicz et al. · Cell Reports Medicine · 2023 · 183 citations · Full text

Life Sciences, Immunology, Oncology +17

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

Yuko Tanabe, Kenji Hashimoto, Chikako Shimizu et al. · International Journal of Clinical Oncology · 2011 · 161 citations

Medicine, Oncology, Pharmacology +16

Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma

Yoshiko Watanabe, Fuminori Katou, Haruo Ohtani et al. · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 2010 · 155 citations

Life Sciences, Immunology, Oncology +17